Cargando…
Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues
BACKGROUND: The use of blood biomarkers after mild traumatic brain injury (mTBI) has been widely studied. We have identified eight unresolved issues related to the use of five commonly investigated blood biomarkers: neurofilament light chain, ubiquitin carboxy-terminal hydrolase-L1, tau, S100B, and...
Autores principales: | Hier, Daniel B., Obafemi-Ajayi, Tayo, Thimgan, Matthew S., Olbricht, Gayla R., Azizi, Sima, Allen, Blaine, Hadi, Bassam A., Wunsch, Donald C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447604/ https://www.ncbi.nlm.nih.gov/pubmed/34530937 http://dx.doi.org/10.1186/s40364-021-00325-5 |
Ejemplares similares
-
A Kinetic Model for Blood Biomarker Levels After Mild Traumatic Brain Injury
por: Azizi, Sima, et al.
Publicado: (2021) -
Computational learning approaches to data analytics in biomedical applications
por: Wunsch, Donald, et al.
Publicado: (2019) -
Evaluation of standard and semantically-augmented distance metrics for neurology patients
por: Hier, Daniel B., et al.
Publicado: (2020) -
Tau kinetics in Alzheimer's disease
por: Hier, Daniel B., et al.
Publicado: (2022) -
Pharmacotherapy of Patients with Mild Persistent Asthma: Strategies and Unresolved Issues
por: Montuschi, Paolo
Publicado: (2011)